Gain Therapeutics Appoints C Evan Ballantyne as Chief Financial Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
BETHESDA, Md., April 12, 2023 Gain Therapeutics, Inc. , a biotechnology company leading the discovery and development of allosteric small molecule therapies, today announced the appointment of. | June 19, 2023
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
Gain Therapeutics (NASDAQ:GANX – Get Rating) had its price target boosted by Chardan Capital from $4.00 to $5.75 in a research report released on Monday, The Fly reports. Gain Therapeutics Stock Up 3.0 % GANX opened at $4.82 on Monday. The company has a debt-to-equity ratio of 0.03, a current ratio of 5.11 and a […]
Gain Therapeutics (GANX) to Present Positive Preclinical Data on its GBA1 Program streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.